During the past decade, Pasadena Liver Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pasadena Liver Center" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Pharmaceutical Research Associates" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pasadena Liver Center" are "Hepatitis C, Chronic" (1 trials), "Non-Alcoholic Fatty Liver Disease" (1 trials), "Nonalcoholic Steatohepatitis" (1 trials) and "Primary Biliary Cholangitis" (1 trials). Many other conditions were trialed in "Pasadena Liver Center" in a lesser frequency.

Most popular intervention types in "Pasadena Liver Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cenicriviroc" (1 trials), "EDP-305 1 mg" (1 trials), "EDP-305 2.5 mg" (1 trials) and "Lovaza" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pasadena Liver Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Pasadena Liver Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pasadena Liver Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pasadena Liver Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".